Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in Type 2 Diabetes Mellitus (T2DM) With Severe Hyperglycemia

被引：0
|
作者：
Babu, Ambika
Barcham, Samih
Daniel, Louis
Fogelfeld, Leon
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1059-P
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [21] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [22] Retrospective study of type 2 diabetes mellitus (T2DM) patients not optimally controlled by metformin monotherapy
    He, J.
    Neslusan, C.
    VALUE IN HEALTH, 2008, 11 (03) : A18 - A18
  • [23] The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Hayder M. Al-kuraishy
    Ali I. Al-Gareeb
    Hebatallah M. Saad
    Gaber El-Saber Batiha
    Inflammopharmacology, 2023, 31 : 1751 - 1760
  • [24] The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Saad, Hebatallah M.
    Batiha, Gaber El-Saber
    INFLAMMOPHARMACOLOGY, 2023, 31 (04) : 1751 - 1760
  • [25] THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY
    Erhardt, W.
    Bergenheim, K.
    Townsend, R.
    Puelles, Fernandez de Troconiz J.
    McEwan, P.
    VALUE IN HEALTH, 2010, 13 (07) : A291 - A292
  • [26] Efficacy and Tolerability of Saxagliptin (SAXA) in Patients With Type 2 Diabetes Mellitus (T2DM) and a History of Cardiovascular Disease (CVD)
    Minervini, Gianmaria
    Cook, William
    Allen, Elsie
    DIABETES, 2013, 62 : A306 - A306
  • [27] THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
    Kolasa, K.
    Niewada, M.
    de Troconiz, J. Puelles Fernandez
    Townsend, R.
    McEwan, P.
    VALUE IN HEALTH, 2010, 13 (07) : A290 - A290
  • [28] SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE (XR) FOR THE TYPE 2 DIABETES (T2DM) TREATMENT IN VENEZUELA: A BUDGET IMPACT ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Perez Monteverde, A.
    Garrido Lecca, S.
    Aiello, E.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A243 - A243
  • [29] Rosiglitazone (RSG) is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T2DM)
    Kreider, M
    Miller, E
    Patel, J
    DIABETES, 1999, 48 : A117 - A117
  • [30] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
12345